Lancet
久々に論文の話を。Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition188カ国の1990…
Mortality in patients treated with extended duration dualantiplatelet therapy after drug-eluting stent implantation:a pairwise and Bayesian network meta-analysis ofrandomised trials心筋梗塞に薬剤溶出ステント（DES）を留置した後には、抗血小…
Prediction of perinatal depression from adolescence and before conception (VIHCS): 20-year prospective cohort study 周産期うつは、高所得国では女性の10-15%に認められるそうです。それの予測が可能なのではないかという、20年に及ぶ大規模な前向き…
Lancet. 2015 Jun 13;385(9985):2363-70. doi: 10.1016/S0140-6736(14)61836-5. Epub 2015 Mar 6.Digoxin use in patients with atrial fibrillation and adverse cardiovascular outcomes: a retrospective analysis of the Rivaroxaban Once Daily Oral Di…
Lancet. 2015 May 12. pii: S0140-6736(14)62000-6. doi: 10.1016/S0140-6736(14)62000-6. [Epub ahead of print]Prognostic value of grip strength: findings from the Prospective Urban Rural Epidemiology (PURE) study.握力低下について、先進国を中心…
Lancet. 2015 Jun 5. pii: S0140-6736(15)60692-4. doi: 10.1016/S0140-6736(15)60692-4. [Epub ahead of print]Global, regional, and national incidence, prevalence, and years lived with disability for301 acute and chronic diseases and injuries i…
Lancet. 2015 May 29. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3. [Epub ahead of print]Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.閉経後乳がん患者の…
Lancet. 2015 May 7. pii: S0140-6736(14)61774-8. doi: 10.1016/S0140-6736(14)61774-8. [Epub ahead of print]50 year trends in atrial fibrillation prevalence, incidence, risk factors, and mortality in theFramingham Heart Study: a cohort study.…
Lancet. 2015 Apr 29. pii: S0140-6736(15)60296-3. doi: 10.1016/S0140-6736(15)60296-3. [Epub ahead of print]The future of life expectancy and life expectancy inequalities in England and Wales: Bayesian spatiotemporal forecasting.＜内容＞ベイ…
Lancet. 2015 May 19. pii: S0140-6736(14)62223-6. doi: 10.1016/S0140-6736(14)62223-6. [Epub ahead of print]Primary chemotherapy versus primary surgery for newly diagnosed advanced ovariancancer (CHORUS): an open-label, randomised, controlle…
Lancet. 2015 May 23;385(9982):2088-95. doi: 10.1016/S0140-6736(14)61460-4. Epub 2015 Feb 4.Socioeconomic inequalities in adolescent health 2002-2010: a time-series analysis of 34countries participating in the Health Behaviour in School-age…
Lancet. 2015 May 23;385(9982):2047-56. doi: 10.1016/S0140-6736(14)62459-4.Comparative efficacy and safety of blood pressure-lowering agents in adults with diabetes and kidney disease: a network meta-analysis.糖尿病性腎症（糖尿病が進んで腎…
Lancet. 2015 Mar 14;385(9972):966-76. doi: 10.1016/S0140-6736(15)60264-1.Global trends and projections for tobacco use, 1990-2025: an analysis of smokingindicators from the WHO Comprehensive Information Systems for Tobacco ControlWHO加盟国…
Financing universal health coverage—effects of alternative tax structures on public health systems: cross-national modelling in 89 low-income and middle-income countries海外ではオバマケアなど、保険制度への注目が高まっています。そんななかで…
Worldwide access to treatment for end-stage kidney disease: a systematic review世界中で腎移植や透析などの腎代替療法を受ける人数についての予測論文です。＜内容＞2010年には262万人だったのが2030年には490万人から970万人に増加する。その結果、最…
Ceftolozane-tazobactam compared with levofloxacin in the treatment of complicated urinary-tract infections, including pyelonephritis: a randomised, double-blind, phase 3 trial (ASPECT-cUTI)複雑性下部尿路感染症または腎盂腎炎に対する新規抗菌…
論文ご紹介。Lancetという世界五大医学雑誌の一つからです。COI（利益相反）を書いてみましたが、臨床試験がほとんどですので、製薬会社が資金源なのは当たり前です。まあ、試験結果をみるときにそれを考慮しましょうという程度です。1. Menopausal hormone …
